RZLT - Rezolute, Inc.
3.18
-0.030 -0.943%
Share volume: 1,365,180
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$3.21
-0.03
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 05-15-2024 | 01-07-2025 | 11-07-2024 | 02-12-2025 | 05-13-2025 | 09-17-2025 | 11-06-2025 | 02-12-2026 | |
| Assets | |||||||||
| Total Assets | 87.737 M | 132.737 M | 123.414 M | 112.007 M | 94.739 M | 175.490 M | 158.664 M | 138.629 M | |
| Current Assets | 82.210 M | 128.653 M | 110.178 M | 98.694 M | 88.735 M | 171.145 M | 154.708 M | 135.106 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 74.092 M | 56.478 M | 97.801 M | 87.608 M | 72.296 M | 73.751 M | 143.096 M | 120.994 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 5.930 M | 70.396 M | 10.472 M | 8.932 M | 14.596 M | 94.107 M | 9.098 M | 11.944 M | |
| Total Non-current Assets | 1.573 M | 263.000 K | 9.552 M | 8.775 M | 1.514 M | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 110.000 K | 103.000 K | 95.000 K | 87.000 K | 80.000 K | 72.000 K | 64.000 K | 57.000 K | |
| Other Assets | 5.417 M | 3.981 M | 13.141 M | 13.226 M | 5.924 M | 4.273 M | 3.892 M | 3.466 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 87.737 M | 132.737 M | 123.414 M | 112.007 M | 94.739 M | 175.490 M | 158.664 M | 138.629 M | |
| Total liabilities | 16.876 M | 11.734 M | 9.973 M | 12.418 M | 12.170 M | 13.363 M | 11.496 M | 10.631 M | |
| Total current liabilities | 6.957 M | 9.606 M | 7.991 M | 10.608 M | 10.527 M | 11.912 M | 10.209 M | 9.529 M | |
| Accounts Payable | 3.499 M | 4.901 M | 2.176 M | 3.149 M | 6.502 M | 5.809 M | 3.259 M | 3.783 M | |
| Other liabilities | 9.919 M | 2.128 M | 1.982 M | 1.810 M | 1.643 M | 1.451 M | 1.287 M | 1.102 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 9.919 M | 2.128 M | 1.982 M | 1.810 M | 1.643 M | 1.451 M | 1.287 M | 1.102 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 70.861 M | 121.003 M | 113.441 M | 99.589 M | 82.569 M | 162.127 M | 147.168 M | 127.998 M | |
| Common stock | 377.407 M | 450.526 M | 457.974 M | 460.077 M | 461.992 M | 565.990 M | 569.125 M | 572.731 M | |
| Retained earnings | -306.468 M | -329.444 M | -344.822 M | -360.552 M | -379.466 M | -403.856 M | -422.006 M | -444.780 M |